Literature DB >> 12444305

The global epidemic of atherosclerotic cardiovascular disease.

Salim Yusuf1, Stephanie Ounpuu, Sonia Anand.   

Abstract

Of the 50 million deaths that occur in the world, 40 million occur in developing countries. Already a substantial proportion of these deaths are due to cardiovascular diseases. It is projected that by the year 2025 well over 80-90% of all the cardiovascular diseases in the world will be occurring in low income and middle income countries. This increase in cardiovascular disease is due to a number of causes which include the following: (1) conquest of deaths in childhood and infancy from nutritional deficiencies and infection; (2) urbanization with increasing levels of obesity; (3) increasing longevity of the population so that a higher proportion of individuals reach the age when they are subject to chronic diseases, and (4) increasing use of tobacco worldwide. In most countries in the world other than those in the West, the burden of disease is still due to a combination of infections and nutritional disorders as well as those due to chronic diseases. This double burden of disease poses a challenge that is not only medical and epidemiological, but also social and political. Tackling this projected global epidemic of cardiovascular disease therefore needs policies that combine sound knowledge of prevention, good clinical care, but also deals with the allocation of resources for both individual level and community level preventive strategies. The former involves dealing with high-risk individuals through appropriate medical and therapeutic interventions. The latter involves societal level changes including laws that curb the use of tobacco, and strategies that promote physical activities, and appropriate nutrition. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12444305     DOI: 10.1159/000066416

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  9 in total

Review 1.  Genetic lipoprotein disorders and coronary atherosclerosis.

Authors:  Mahmoud Alawadhi; George Thanassoulis; Michel Marcil; Jacques Genest
Journal:  Curr Atheroscler Rep       Date:  2005-05       Impact factor: 5.113

Review 2.  Nox1 downregulators: A new class of therapeutics.

Authors:  Matthias Barton; Matthias R Meyer; Eric R Prossnitz
Journal:  Steroids       Date:  2019-09-10       Impact factor: 2.668

Review 3.  Heart failure: epidemiology and prevention in India.

Authors:  Mark D Huffman; Dorairaj Prabhakaran
Journal:  Natl Med J India       Date:  2010 Sep-Oct       Impact factor: 0.537

4.  High levels of thyroid-stimulating hormone are associated with aortic wall thickness in the general population.

Authors:  Till Ittermann; Roberto Lorbeer; Marcus Dörr; Tobias Schneider; Alexander Quadrat; Lydia Heßelbarth; Michael Wenzel; Ina Lehmphul; Josef Köhrle; Birger Mensel; Henry Völzke
Journal:  Eur Radiol       Date:  2016-03-14       Impact factor: 5.315

5.  Aspirin-loaded electrospun poly(ε-caprolactone) tubular scaffolds: potential small-diameter vascular grafts for thrombosis prevention.

Authors:  Costantino Del Gaudio; Enrico Ercolani; Pierluca Galloni; Federico Santilli; Silvia Baiguera; Leonardo Polizzi; Alessandra Bianco
Journal:  J Mater Sci Mater Med       Date:  2012-11-08       Impact factor: 3.896

6.  Lipopolysaccharide promotes lipid accumulation in human adventitial fibroblasts via TLR4-NF-κB pathway.

Authors:  Jun Wang; Yanfang Si; Chen Wu; Lu Sun; Yudong Ma; Aili Ge; Baomin Li
Journal:  Lipids Health Dis       Date:  2012-10-17       Impact factor: 3.876

7.  The Urotensin II System and Carotid Atherosclerosis: A Role in Vascular Calcification.

Authors:  Isabella Albanese; Stella S Daskalopoulou; Bin Yu; Zhipeng You; Jacques Genest; Alawi Alsheikh-Ali; Adel G Schwertani
Journal:  Front Pharmacol       Date:  2016-06-07       Impact factor: 5.810

Review 8.  Obesity Among Young Adults in Developing Countries: A Systematic Overview.

Authors:  Amudha Poobalan; Lorna Aucott
Journal:  Curr Obes Rep       Date:  2016-03

9.  Cardiovascular disease events and its predictors in women: Isfahan Cohort Study (ICS).

Authors:  Masoumeh Sadeghi; Azam Soleimani; Hamidreza Roohafza; Safoura Yazdekhasti; Shahram Oveisgharan; Mohammad Talaei; Nizal Sarrafzadegan
Journal:  J Cardiovasc Thorac Res       Date:  2017-08-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.